New hope for leukemia patients who stopped responding to standard treatments
Disease control
Recruiting now
This study tests a new drug called ELVN-001 for people with chronic myeloid leukemia (CML) whose cancer has stopped responding to or who cannot tolerate current treatments. About 250 adults with CML will receive the drug to find the safest dose and check for side effects. The goa…
Phase: PHASE1 • Sponsor: Enliven Therapeutics • Aim: Disease control
Last updated May 17, 2026 04:46 UTC